Precision Oncology Market Size, Share, Trends, Growth Outlook

Precision Oncology Market is estimated to increase at a growth rate of 10.7% CAGR over the forecast period from 2024 to 2030.

The global Precision Oncology Marketstudy analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Product (Diagnostics, Therapeutics), By Cancer (Breast Cancer, Colorectal Cancer, Cervical Cancer, Prostate Cancer, Lung Cancer, Others), By End-user (Hospitals & Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies, Healthcare Data Companies).

An introduction to Precision Oncology Market in 2024

The precision oncology market is witnessing remarkable growth in 2024, driven by advancements in genomics, molecular diagnostics, and targeted cancer therapies, and the growing recognition of the heterogeneity of cancer and the importance of personalized treatment approaches. Precision oncology utilizes genomic profiling, biomarker testing, and molecularly targeted therapies to tailor cancer treatment strategies to the genetic makeup of individual tumors, maximizing therapeutic efficacy while minimizing adverse effects. With innovations in next-generation sequencing, liquid biopsy technologies, and immunotherapy modalities, the market is experiencing rapid expansion and adoption of precision oncology approaches across various cancer types, revolutionizing cancer care delivery and improving patient outcomes.

Precision Oncology Market Trend: Advancements in Genomic Sequencing Technologies

A prominent trend in the Precision Oncology Market is the rapid advancements in genomic sequencing technologies. These technologies, such as next-generation sequencing (NGS) and single-cell sequencing, are enabling researchers and clinicians to analyze the genetic makeup of tumors with unprecedented accuracy and detail. By identifying specific genetic alterations and mutations driving cancer growth, precision oncology approaches can tailor treatment strategies to target these molecular abnormalities, leading to more personalized and effective cancer therapies.

Precision Oncology Market Driver: Increasing Demand for Targeted Cancer Therapies

The primary driver of the Precision Oncology Market is the increasing demand for targeted cancer therapies. Traditional cancer treatments, such as chemotherapy and radiation therapy, often have limited efficacy and can cause significant side effects due to their non-specific nature. In contrast, targeted therapies aim to selectively target cancer cells based on specific molecular alterations, offering the potential for improved treatment outcomes and reduced toxicity. As awareness of the benefits of precision oncology continues to grow among patients and healthcare providers, there is a rising demand for innovative targeted therapies that can address the underlying genetic drivers of cancer.

Precision Oncology Market Opportunity: Expansion of Companion Diagnostic Testing

An opportunity within the Precision Oncology Market lies in the expansion of companion diagnostic testing. Companion diagnostics are tests that identify biomarkers or genetic mutations associated with a patient's cancer, helping to guide treatment decisions by identifying individuals who are most likely to benefit from specific targeted therapies. As the field of precision oncology expands and more targeted therapies enter the market, there is a growing need for companion diagnostics to accurately identify patients who are suitable candidates for these treatments. By developing and commercializing companion diagnostic tests in conjunction with novel targeted therapies, companies can capitalize on this opportunity to improve patient outcomes and enhance the value proposition of precision oncology interventions.

Precision Oncology Market Market Segmentation

By Product
Diagnostics
Therapeutics
By Cancer
Breast Cancer
Colorectal Cancer
Cervical Cancer
Prostate Cancer
Lung Cancer
Others
By End-User
Hospitals & Diagnostic Laboratories
Pharmaceutical & Biotechnology Companies
Healthcare Data Companies

Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

Precision Oncology Market Companies

Acrivon Therapeutics
Bioserve
Exact Sciences Corp
Illumina Inc
Invitae Corp
Laboratory Corp Of America Holding
Qiagen N.V.
Rain Oncology Inc
Relay Therapeutics
Strata Oncology Inc
Thermo Fisher Scientific Inc
Variantyx Inc
Xilis Inc

Reasons to Buy the Precision Oncology Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Precision Oncology Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Precision Oncology Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

TABLE OF CONTENTS

1 Introduction to 2024 Precision Oncology Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain

2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations

3 Executive Summary
3.1 Global Precision Oncology Market Size Outlook, $ Million, 2021 to 2030
3.2 Precision Oncology Market Outlook by Type, $ Million, 2021 to 2030
3.3 Precision Oncology Market Outlook by Product, $ Million, 2021 to 2030
3.4 Precision Oncology Market Outlook by Application, $ Million, 2021 to 2030
3.5 Precision Oncology Market Outlook by Key Countries, $ Million, 2021 to 2030

4 Market Dynamics
4.1 Key Driving Forces of Precision Oncology Industry
4.2 Key Market Trends in Precision Oncology Industry
4.3 Potential Opportunities in Precision Oncology Industry
4.4 Key Challenges in Precision Oncology Industry

5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Precision Oncology Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook

6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts

7 Global Precision Oncology Market Outlook by Segments
7.1 Precision Oncology Market Outlook by Segments, $ Million, 2021- 2030
By Product
Diagnostics
Therapeutics
By Cancer
Breast Cancer
Colorectal Cancer
Cervical Cancer
Prostate Cancer
Lung Cancer
Others
By End-User
Hospitals & Diagnostic Laboratories
Pharmaceutical & Biotechnology Companies
Healthcare Data Companies

8 North America Precision Oncology Market Analysis and Outlook To 2030
8.1 Introduction to North America Precision Oncology Markets in 2024
8.2 North America Precision Oncology Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Precision Oncology Market size Outlook by Segments, 2021-2030
By Product
Diagnostics
Therapeutics
By Cancer
Breast Cancer
Colorectal Cancer
Cervical Cancer
Prostate Cancer
Lung Cancer
Others
By End-User
Hospitals & Diagnostic Laboratories
Pharmaceutical & Biotechnology Companies
Healthcare Data Companies

9 Europe Precision Oncology Market Analysis and Outlook To 2030
9.1 Introduction to Europe Precision Oncology Markets in 2024
9.2 Europe Precision Oncology Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Precision Oncology Market Size Outlook by Segments, 2021-2030
By Product
Diagnostics
Therapeutics
By Cancer
Breast Cancer
Colorectal Cancer
Cervical Cancer
Prostate Cancer
Lung Cancer
Others
By End-User
Hospitals & Diagnostic Laboratories
Pharmaceutical & Biotechnology Companies
Healthcare Data Companies

10 Asia Pacific Precision Oncology Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Precision Oncology Markets in 2024
10.2 Asia Pacific Precision Oncology Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Precision Oncology Market size Outlook by Segments, 2021-2030
By Product
Diagnostics
Therapeutics
By Cancer
Breast Cancer
Colorectal Cancer
Cervical Cancer
Prostate Cancer
Lung Cancer
Others
By End-User
Hospitals & Diagnostic Laboratories
Pharmaceutical & Biotechnology Companies
Healthcare Data Companies

11 South America Precision Oncology Market Analysis and Outlook To 2030
11.1 Introduction to South America Precision Oncology Markets in 2024
11.2 South America Precision Oncology Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Precision Oncology Market size Outlook by Segments, 2021-2030
By Product
Diagnostics
Therapeutics
By Cancer
Breast Cancer
Colorectal Cancer
Cervical Cancer
Prostate Cancer
Lung Cancer
Others
By End-User
Hospitals & Diagnostic Laboratories
Pharmaceutical & Biotechnology Companies
Healthcare Data Companies

12 Middle East and Africa Precision Oncology Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Precision Oncology Markets in 2024
12.2 Middle East and Africa Precision Oncology Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Precision Oncology Market size Outlook by Segments, 2021-2030
By Product
Diagnostics
Therapeutics
By Cancer
Breast Cancer
Colorectal Cancer
Cervical Cancer
Prostate Cancer
Lung Cancer
Others
By End-User
Hospitals & Diagnostic Laboratories
Pharmaceutical & Biotechnology Companies
Healthcare Data Companies

13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Acrivon Therapeutics
Bioserve
Exact Sciences Corp
Illumina Inc
Invitae Corp
Laboratory Corp Of America Holding
Qiagen N.V.
Rain Oncology Inc
Relay Therapeutics
Strata Oncology Inc
Thermo Fisher Scientific Inc
Variantyx Inc
Xilis Inc
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise

By Product
Diagnostics
Therapeutics
By Cancer
Breast Cancer
Colorectal Cancer
Cervical Cancer
Prostate Cancer
Lung Cancer
Others
By End-User
Hospitals & Diagnostic Laboratories
Pharmaceutical & Biotechnology Companies
Healthcare Data Companies